Oracle Cancer Trust is the UK's national leading charity solely dedicated to funding research into head and neck cancer.

Over the past ten years, Oracle has invested over £5 million in world-class research programmes discovering new and improved treatments with fewer immediate and long-term side effects for patients suffering from head and neck cancer.

Oracle’s pioneering research work, led by some of the world’s leading authorities on head and neck cancer treatment has resulted in breakthroughs in delivering new surgical techniques, radiotherapy treatment, speech and language therapy, drug development and virus and immunotherapies.

Oracle’s vision is to continue to focus on funding early-stage research and proof-of-concept projects.  The charity is laying the scientific foundations for larger-scale clinical trials and commercial research - filling a 'research gap’. Oracle receives no government funding and relies entirely on charitable donations to carry out its vital work.